Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Universite De Montreal patents

Recent patent applications related to Universite De Montreal. Universite De Montreal is listed as an Agent/Assignee. Note: Universite De Montreal may have other listings under different names/spellings. We're not affiliated with Universite De Montreal, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite De Montreal-related inventors

Electrode materials with high surface conductivity

The present invention concerns electrode materials capable of redox reactions by electron and alkali-ion exchange with an electrolyte. The applications are in the field of primary (batteries) or secondary electrochemical generators, supercapacitors and light modulating systems of the electrochromic type.. ... Universite De Montreal

Benzothiazole and benzothiophene compounds

The present invention provides benzothiazole compounds or benzothiophene compounds of formula i having the structure: wherein x1, x2, x3, x4, x5, y, wr2, r3, r4, r5, r6, r7 and aa and other moieties are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.. ... Universite De Montreal

Combination therapy using ribavirin as eif4e inhibitor

The present invention relates to pharmaceutical compositions and combination therapies for treating patients having a neoplasm or a proliferative disorder, the combination comprises an inhibitor of the eif4e gene product and a chemotherapeutic agent, wherein said combination therapy overcomes resistance developed in patients during anti-neoplastic treatment. The present invention also provides for the use of a combination therapy for treating patients having a neoplasm, a proliferative disorder, pre-neoplasm or a precancerous lesion, comprising an inhibitor of the eif4e gene product, a chemotherapeutic agent, and a therapeutically effective amount of a hedgehog pathway inhibitor; and the method of using said combination therapy.. ... Universite De Montreal

18-20 member bi-polycyclic compounds

The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.. . ... Universite De Montreal

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Universite De Montreal in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite De Montreal with additional patents listed. Browse our Agent directory for other possible listings. Page by